Newsletters

priadel sertraline Prescribing Incentive scheme lithium recent decision BSW Systmone Formulary webinars DES opioids fentanyl methotrexate care home (MOCH) newsletter

cost-effective switches prescribe well, spend less DOACS steroid care warfarin Medicines Management Team BSW cost savings opportunities BSW Area Prescribing Committee APC meeting dates webinars… Read More »Issue 8 – Medicines Optimisation Update – September 2020

Antibiotic MC+S Valproic Dep[akote Convulex Belvo Diverticulitis Co-amoxiclav Cellulitis Flucloxacillin Diabetic foot sensitivity 88f20000 self care testosterone co-dantrhamer danthruser picato ingenol mebutate actinic keratosis MOCH… Read More »Issue 7 – Medicines Optimisation Update – February 2020

phenytoin supply disruption alert CAS report colestyramine supply problems malabsorption disorders bile acid questran light colestipol medicines shortages slozem to viazem XL diltiazem domperidone dieticians… Read More »Issue 6 – Medicines Optimisation Update – January 2020

DOAC weight CrCl oxycodone amitriptyline GLP-1 Cannabis nausea vomiting pain spasticity epilepsy cannabinoids sativex MS Nabilone Epidyolex creatinine clearance respiratory depression melatonin slenyto semaglutide hypertension… Read More »Issue 5 – Medicines Optimisation Update – November/December 2019

Cannabis CBD Antibiotic creams excetra dermol aproderm epimax eczema psoriasis glycerine cetraben ulcers antimicrobial emollient OTC Octreotide Diprobase Hydromol Lidocaine Nordimet Methotrexate Cortiment Budesonide R1… Read More »Newsletter 128 – September & October 2018

Ranitidine Bunov Buprenorphine Vencarm Venlafaxine Respimat Spiriva Spiolto Striverdi Zantac Catephen® ointment Strontium Ranelate Ospemifene Co-danthramer & Co-danthrusate Fluomizin® Dequalinium Utrogestan® Softacort® Hydrocortisone Paravit CF… Read More »Issue 4 – Medicines Optimisation Update – October 2019

HRT Breast menopausal hydroxychloroquine retinopathy sunscreens uvistat vitamin D colecalciferol testosterone testogel quinagolide norprolac hydrocortisone solucortef lidocaine xaggitin methylphenidate beclomethasone kelhale qvar ertugliflozin steglatro toujeo… Read More »Issue 3 – Medicines Optimisation Update – September 2019

opioid sean pain creatinine crcl eGFR edoxaban QoF NSAID Lithium Valproate Rivaroxaban Emerade adrenaline Qvar Trimovate Ertugliflozin Kelhale G Fixapost (latanoprost / timolol) eye drops… Read More »Issue 2 – Medicines Optimisation Update – July/August 2019

Antimicrobial resistance DOAC Antiphospholipid syndrome Rivaroxaban Apixaban Edoxaban Dabigatran Opicapone Semaglutide Utrogestan Letrozole Elleste solo estradiol progynova zumenon Elleste duet conti kliofem norethisterone freestyle libre… Read More »Issue 1 – Medicines Optimisation Update – June 2019